Laboratory investigations are necessary to establish the source of an outbreak , to determine whether chemotherapy is necessary as it is in , for example , Giardia lamblia infection and to identify long - term changes in the pattern of infections related to altered dietary habits and other social factors .	entity* Laboratory investigations *entity are necessary to establish the entity* source of an outbreak *entity , to determine whether entity* chemotherapy *entity is necessary as it is in , for example , entity* Giardia lamblia infection *entity and to entity* identify long - term changes *entity in the entity* pattern of infections *entity related to entity* altered dietary habits *entity and other entity* social factors *entity .
In this survey we draw attention to the many infective agents which have to be considered in the investigation of cases and outbreaks of gastroenteritis .	In this survey we draw attention to the many entity* infective agents *entity which have to be considered in the entity* investigation of cases and outbreaks *entity of entity* gastroenteritis *entity .
Publisher Summary Many pathogens have been reported to cause disease in the laboratory rat .	Publisher Summary Many entity* pathogens *entity have been reported to entity* cause disease in the laboratory rat *entity .
Based on serologic surveys , parvo viruses are some of the most common viral pathogens in wild and laboratory rat .	Based on entity* serologic surveys *entity , entity* parvo viruses *entity are some of the most common viral pathogens in wild and laboratory entity* rat *entity .
However , RPV is antigenically and genetically distinct from RV , and it apparently does not cause clinical signs or lesions in infant rats .	However , entity* RPV *entity is entity* antigenically and genetically distinct from RV *entity , and it apparently does not cause clinical signs or lesions in infant rats .
Both RPV and RV are tropic for many of the same tissues and they both may result in a persistent infection .	Both entity* RPV *entity and entity* RV *entity are tropic for many of the same tissues and they both may result in a entity* persistent infection *entity .
The infection in young rats is usually clinically silent .	The entity* infection in young rats *entity is usually entity* clinically silent *entity .
In older rats , there are nonspecific clinical signs such as snuffling , chromodacryorrhea , and face and ear rubbing .	In entity* older rats *entity , there are nonspecific clinical signs such as entity* snuffling *entity , entity* chromodacryorrhea *entity , and entity* face and ear rubbing *entity .
Several bacteria of the genus Streptococcus can cause clinical disease in rats .	Several entity* bacteria of the genus Streptococcus *entity can cause entity* clinical disease in rats *entity .
In rats , infection is usually asymptomatic although nonspecific clinical signs , such as weight loss and dyspnea , may be observed .	In rats , entity* infection *entity is usually entity* asymptomatic *entity although entity* nonspecific clinical signs *entity , such as entity* weight loss *entity and entity* dyspnea *entity , may be observed .
Publisher Summary This chapter discusses the utility and safety of xenogenic vectors for vaccination or gene delivery .	Publisher Summary This chapter discusses the utility and safety of entity* xenogenic vectors *entity for entity* vaccination *entity or entity* gene delivery *entity .
The properties and behavior of these vectors in heterologous situations are also discussed .	The properties and behavior of these entity* vectors *entity in entity* heterologous situations *entity are also discussed .
Ideally , vectors for gene transfer into human cells should be capable of transgene expression without replication or detrimental expression of viral genes .	Ideally , entity* vectors *entity for entity* gene transfer into human cells *entity should be capable of entity* transgene expression without replication *entity or detrimental expression of viral genes .
Infection of human cell lines with intact xenogenic adenoviruses established the principle that these viruses are replication defective at the inputs tested , although the molecular basis for defective replication is not understood .	entity* Infection of human cell lines *entity with intact entity* xenogenic adenoviruses *entity established the principle that these entity* viruses are replication defective at the inputs tested *entity , although the molecular basis for defective replication is not understood .
Most work with xenogenic vectors is still firmly based in the laboratory and while this is appropriate to demonstrate the utility of a vector the amount of work required for eventual exploitation of a vector in the clinic should not be underestimated .	Most entity* work *entity with entity* xenogenic vectors *entity is still firmly based in the entity* laboratory *entity and while this is appropriate to entity* demonstrate the utility of a vector *entity the amount of work required for eventual entity* exploitation of a vector in the clinic *entity should not be underestimated .
Understanding the biology of these vectors will ultimately lead to an increased choice of gene delivery vectors , providing more options in therapeutic strategy and design .	entity* Understanding the biology of these vectors *entity will ultimately lead to an entity* increased choice of gene delivery vectors *entity , providing more entity* options *entity in entity* therapeutic strategy *entity and entity* design *entity .
Abstract In order to mitigate human and financial losses as a result of future global pandemics , we must plan now .	Abstract In order to entity* mitigate human and financial losses *entity as a result of future global entity* pandemics *entity , we must entity* plan now *entity .
As the Ebola virus pandemic declines , we must reflect on how we have mismanaged this recent international crisis and how we can better prepare for the next global pandemic .	As the Ebola virus pandemic declines , we must entity* reflect on how we have mismanaged this recent international crisis *entity and how we can entity* better prepare for the next global pandemic *entity .
This editorial discusses many issues including priority emerging and re - emerging infectious diseases ; the challenges of meeting international health regulations ; the strengthening of global health systems ; global pandemic funding ; and the One Health approach to future pandemic planning .	This editorial discusses many issues including priority emerging and re - emerging entity* infectious diseases *entity ; the challenges of meeting entity* international health regulations *entity ; the entity* strengthening of global health systems *entity ; global pandemic funding ; and the entity* One Health approach *entity to entity* future pandemic planning *entity .
We recommend that the global health community unites to urgently address these issues in order to avoid the next humanitarian crisis .	We recommend that the entity* global health community unites *entity to urgently entity* address these issues *entity in order to entity* avoid the next humanitarian crisis *entity .
Blood coagulation and inflammation are universal responses to infection and there is crosstalk between inflammation and coagulation that can either amplify or dampen the responses .	entity* Blood coagulation *entity and entity* inflammation *entity are universal responses to entity* infection *entity and there is entity* crosstalk between inflammation and coagulation *entity that can entity* either amplify or dampen the responses *entity .
Loss of appropriate interactions between these systems probably contributes to morbidity and mortality in infectious diseases .	entity* Loss of appropriate interactions between these systems *entity probably entity* contributes to morbidity and mortality in infectious diseases *entity .
For instance , inflammatory cytokines and leukocyte elastase can downregulate natural anticoagulant proteins that help to maintain endothelial - cell integrity , control clotting , inhibit vasoactive peptides and dampen leukocyte infiltration into the vessel wall .	For instance , entity* inflammatory cytokines *entity and entity* leukocyte elastase *entity can entity* downregulate natural anticoagulant proteins *entity that entity* help to maintain endothelial - cell integrity *entity , entity* control clotting *entity , entity* inhibit vasoactive peptides *entity and entity* dampen leukocyte infiltration *entity into the vessel wall .
This Review will summarize our current understanding of the mechanisms involved in the crosstalk between these two important systems .	This Review will summarize our current understanding of the entity* mechanisms *entity involved in the entity* crosstalk between these two important systems *entity .
Abstract The increasing appreciation for the crucial roles of RNAs in infectious and non - infectious human diseases makes them attractive therapeutic targets .	Abstract The increasing appreciation for the crucial roles of entity* RNAs *entity in entity* infectious and non - infectious human diseases *entity makes them attractive entity* therapeutic targets *entity .
Coding and non - coding RNAs frequently fold into complex conformations which , if effectively targeted , offer opportunities to therapeutically modulate numerous cellular processes , including those linked to undruggable protein targets .	entity* Coding and non - coding RNAs *entity frequently entity* fold *entity into complex conformations which , if effectively targeted , offer opportunities to entity* therapeutically modulate numerous cellular processes *entity , including those linked to undruggable protein targets .
Despite the considerable skepticism as to whether RNAs can be targeted with small molecule therapeutics , overwhelming evidence suggests the challenges we are currently facing are not outside the realm of possibility .	Despite the considerable skepticism as to whether entity* RNAs can be targeted *entity with entity* small molecule therapeutics *entity , overwhelming evidence suggests the challenges we are currently facing are not outside the realm of possibility .
In this review , we highlight the most recent advances in molecular techniques that have sparked a revolution in understanding the RNA structure - to - function relationship .	In this review , we highlight the most recent advances in entity* molecular techniques *entity that have sparked a revolution in entity* understanding the RNA structure - to - function relationship *entity .
We bring attention to the application of these modern techniques to identify druggable RNA targets and to assess small molecule binding specificity .	We bring attention to the application of these entity* modern techniques *entity to entity* identify druggable RNA targets *entity and to entity* assess small molecule binding specificity *entity .
Finally , we discuss novel screening methodologies that support RNA drug discovery and present examples of therapeutically valuable RNA targets .	Finally , we discuss entity* novel screening methodologies *entity that entity* support RNA drug discovery *entity and entity* present examples of therapeutically valuable RNA targets *entity .
Abstract Complications of prematurity often disrupt normal brain development and/or cause direct damage to the developing brain , resulting in poor neurodevelopmental outcomes .	Abstract entity* Complications of prematurity *entity often entity* disrupt normal brain development *entity and/or entity* cause direct damage to the developing brain *entity , resulting in entity* poor neurodevelopmental outcomes *entity .
Physiologically relevant animal models of perinatal brain injury can advance our understanding of these influences and thereby provide opportunities to develop therapies and improve long - term outcomes .	Physiologically relevant entity* animal models of perinatal brain injury *entity can entity* advance our understanding of these influences *entity and thereby provide opportunities to entity* develop therapies *entity and entity* improve long - term outcomes *entity .
While there are advantages to currently available small animal models , there are also significant drawbacks that have limited translation of research findings to humans .	While there are advantages to currently available entity* small animal models *entity , there are also significant drawbacks that have entity* limited translation of research findings to humans *entity .
Large animal models such as newborn pig , sheep and nonhuman primates have complex brain development more similar to humans , but these animals are expensive , and developmental testing of sheep and piglets is limited .	entity* Large animal models *entity such as newborn pig , sheep and nonhuman primates have entity* complex brain development *entity more similar to humans , but these animals are expensive , and developmental testing of sheep and piglets is limited .
Ferrets ( Mustela putorius furo ) are born lissencephalic and undergo postnatal cortical folding to form complex gyrencephalic brains .	entity* Ferrets *entity ( Mustela putorius furo ) are entity* born lissencephalic *entity and undergo entity* postnatal cortical folding *entity to entity* form complex gyrencephalic brains *entity .
This review examines whether ferrets might provide a novel intermediate animal model of neonatal brain disease that has the benefit of a gyrified , altricial brain in a small animal .	This review examines whether entity* ferrets *entity might provide a novel intermediate animal entity* model *entity of entity* neonatal brain disease *entity that has the benefit of a entity* gyrified , altricial brain *entity in a small animal .
It summarizes attributes of ferret brain growth and development that make it an appealing animal in which to model perinatal brain injury .	It summarizes attributes of entity* ferret brain growth and development *entity that make it an appealing animal in which to entity* model perinatal brain injury *entity .
We postulate that because of their innate characteristics , ferrets have great potential in neonatal neurodevelopmental studies .	We postulate that because of their innate characteristics , entity* ferrets *entity have great potential in entity* neonatal neurodevelopmental studies *entity .
Abstract MULTIPRED2 is a computational system for facile prediction of peptide binding to multiple alleles belonging to human leukocyte antigen ( HLA ) class I and class II DR molecules .	Abstract entity* MULTIPRED2 *entity is a computational system for facile entity* prediction of peptide binding to multiple alleles belonging to human leukocyte antigen ( HLA ) class I and class II DR molecules *entity .
Thoracic HRCT scans play an important role in the early diagnosis of new coronavirus ( NCP ) .	entity* Thoracic HRCT scans *entity play an important role in the entity* early diagnosis of new coronavirus ( NCP ) *entity .
Conclusions Lung lesions of NCP patients can be detected for the first time by chest HRCT , which is the preferred imaging method .	Conclusions entity* Lung lesions of NCP patients *entity can be detected for the first time by entity* chest HRCT *entity , which is the preferred imaging method .
Although this particular species has indeed caused the majority of human infections in Central and , recently , West Africa , other ebolavirus species ( e.g	Although entity* this particular species *entity has indeed entity* caused the majority of human infections in Central and , recently , West Africa *entity , other ebolavirus species ( e.g
, Sudan ebolavirus and Bundibugyo ebolavirus ) have also repeatedly caused outbreaks in Central Africa and thus should not be neglected in the development of countermeasures against ebolaviruses .	, entity* Sudan ebolavirus *entity and entity* Bundibugyo ebolavirus *entity ) have also repeatedly entity* caused outbreaks in Central Africa *entity and thus should not be neglected in the development of countermeasures against ebolaviruses .
Here we report the generation of an ebolavirus glycoprotein - specific monoclonal antibody that effectively inhibits cellular entry of representative isolates of all known ebolavirus species in vitro and show its protective efficacy in mouse models of ebolavirus infections .	Here we report the generation of an entity* ebolavirus glycoprotein - specific monoclonal antibody *entity that entity* effectively inhibits cellular entry of representative isolates of all known ebolavirus species in vitro *entity and show its protective efficacy in mouse models of ebolavirus infections .
This novel neutralizing monoclonal antibody targets a highly conserved internal fusion loop in the glycoprotein molecule and prevents membrane fusion of the viral envelope with cellular membranes .	This entity* novel neutralizing monoclonal antibody *entity entity* targets a highly conserved internal fusion loop in the glycoprotein molecule *entity and entity* prevents membrane fusion of the viral envelope with cellular membranes *entity .
The discovery of this highly cross - neutralizing antibody provides a promising option for broad - acting ebolavirus antibody therapy and will accelerate the design of improved vaccines that can selectively elicit cross - neutralizing antibodies against multiple species of ebolaviruses .	The discovery of this entity* highly cross - neutralizing antibody *entity provides a promising option for entity* broad - acting ebolavirus antibody therapy *entity and will accelerate the design of improved entity* vaccines *entity that can entity* selectively elicit cross - neutralizing antibodies *entity against multiple species of entity* ebolaviruses *entity .
The purpose of this study was to assess the clinical features and CT manifestations of COVID-19 by comparing patients with COVID-19 pneumonia with patients with non - COVID-19 pneumonia who presented at a fever observation department in Shanghai , China .	The purpose of this study was to entity* assess the clinical features *entity and entity* CT manifestations of COVID-19 *entity by entity* comparing patients with COVID-19 pneumonia with patients with non - COVID-19 pneumonia who presented at a fever observation department in Shanghai , China *entity .
The present study establishes the fact that darkling beetles serve as vectors for common avian pathogens .	The present study establishes the fact that entity* darkling beetles *entity serve as vectors for entity* common avian pathogens *entity .
Darkling beetles must be considered on a list of other vectors known to transmit common poultry pathogens .	entity* Darkling beetles *entity must be considered on a list of other vectors known to entity* transmit common poultry pathogens *entity .
In this Perspective we detail the linear aRNA amplification procedure and its use in assessing various components of a cell 's chemical phenotype .	In this Perspective we detail the entity* linear aRNA amplification procedure *entity and its use in entity* assessing various components of a cell 's chemical phenotype *entity .
This procedure is particularly useful in efforts to multiplex the simultaneous detection of various cellular processes .	entity* This procedure *entity is particularly useful in entity* efforts to multiplex the simultaneous detection of various cellular processes *entity .
These efforts are necessary to identify the quantitative chemical phenotype of cells that underlies cellular function .	These efforts are necessary to identify the entity* quantitative chemical phenotype *entity of entity* cells that underlies cellular function *entity .
Certain highly hazardous communicable diseases ( HHCD ) , including viral hemorrhagic fevers , the Middle East respiratory syndrome coronavirus ( MERS - CoV ) , and severe acute respiratory syndrome virus ( SARS ) , have caused nosocomial outbreaks in unprepared facilities .	Certain entity* highly hazardous communicable diseases ( HHCD ) *entity , including entity* viral hemorrhagic fevers *entity , entity* the Middle East respiratory syndrome coronavirus ( MERS - CoV ) *entity , and entity* severe acute respiratory syndrome virus ( SARS ) *entity , have caused entity* nosocomial outbreaks in unprepared facilities *entity .
Consequently , biocontainment units have been constructed to protect caregivers , patients , and family members , in addition to providing optimal care of the infected patient .	Consequently , entity* biocontainment units *entity have been constructed to entity* protect caregivers , patients , and family members , in addition to providing optimal care of the infected patient *entity .
Biocontainment units have adopted many of the design features originally found in biocontainment laboratories and can serve as national referral facilities for the most severe and highly hazardous infections .	entity* Biocontainment units *entity have adopted many of the design features originally found in biocontainment laboratories and can serve as entity* national referral facilities for the most severe and highly hazardous infections *entity .
Awareness of the potential risk , in addition to adopting structural and policy control measures , can do a lot to prepare a facility for the next unexpected infectious disease outbreak .	entity* Awareness of the potential risk *entity , in addition entity* to adopting structural and policy control measures , can do a *entity lot to prepare a facility for the next unexpected infectious disease outbreak .
We tested 290 nasal wash specimens from Filipino children < 2 years of age with respiratory tract infections using culture and 3 PCR methods — EraGen , Luminex , and the GIS PathChip .	We entity* tested 290 nasal wash specimens *entity from Filipino children < 2 years of age with respiratory tract infections using entity* culture *entity and 3 entity* PCR methods — EraGen *entity , entity* Luminex *entity , and the entity* GIS PathChip *entity .
Vaccines work by eliciting an immune response and consequent immunological memory that mediates protection from infection or disease .	entity* Vaccines *entity work by entity* eliciting an immune response *entity and consequent entity* immunological memory *entity that mediates entity* protection from infection or disease *entity .
Recently new methods have been developed to dissect the immune response in experimental animals and humans which have led to increased understanding of the molecular mechanisms that control differentiation and maintenance of memory T and B cells .	Recently new methods have been developed to entity* dissect the immune response in experimental animals and humans *entity which have led to entity* increased understanding of the molecular mechanisms that control differentiation and maintenance of memory T and B cells *entity .
Abstract Recent observations and experimental evidence have purported that a virus causes SARS , but such viruses have been isolated in only less than half of SARS patients in some studies and virologist Vincent Plummer of Winnipeg ’s National Microbiology Laboratory found that indeed 1 in 5 perfectly healthy Canadians with a history of recent travel to Asia had the virus .	Abstract Recent observations and experimental evidence have purported that entity* a virus *entity causes entity* SARS *entity , but such viruses have been isolated in only less than half of SARS patients in some studies and virologist Vincent Plummer of Winnipeg ’s National Microbiology Laboratory found that indeed 1 in 5 perfectly healthy Canadians with a history of recent travel to Asia had the virus .
Outbreaks of multi - drug resistant ( MDR ) tuberculosis and the atypical mycobacteria simulate SARS on clinical , radiologic , epidemiologic , and diagnostic laboratory grounds and it is only logical then to include them in the differential to find a definitive cause and cure for SARS .	entity* Outbreaks of multi - drug resistant ( MDR ) tuberculosis and the atypical mycobacteria *entity entity* simulate SARS on clinical , radiologic , epidemiologic , and diagnostic laboratory grounds *entity and it is only logical then entity* to include them in the differential to find a *entity definitive cause and cure for SARS .
Abstract Objective To compare outcomes of early and delayed treatment with cidofovir for human adenovirus ( HAdV ) pneumonia .	Abstract Objective To compare outcomes of early and delayed entity* treatment with cidofovir *entity for entity* human adenovirus ( HAdV ) pneumonia *entity .
Patients with potentially severe HAdV pneumonia with risk factors for respiratory failure were included and divided into early ( within 7 days from symptom onset ) and delayed ( after 7 days from symptom onset ) treatment groups .	Patients with potentially entity* severe HAdV pneumonia *entity with risk factors for entity* respiratory failure *entity were included and divided into early ( within 7 days from symptom onset ) and delayed ( after 7 days from symptom onset ) treatment groups .
Early treatment was associated with a lower 21-day probability of respiratory failure by the Kaplan – Meier method ( p < 0.001 ) .	entity* Early treatment *entity was associated with a entity* lower 21-day probability of respiratory failure *entity by the Kaplan – Meier method ( p < 0.001 ) .
On multivariate analysis , monocyte count , hypoxaemia , confusion , whole lung involvement , and early cidofovir treatment within 7 days from symptom onset were included , and monocyte count ( HR 0.995 , 95%CI 0.991–1.000 , p 0.042 ) , confusion ( HR 4.964 , 95%CI 1.189–20.721 , p = 0.028 ) , and early cidofovir treatment ( HR 0.319 , 95%CI 0.115–0.883 , p = 0.028 ) were significantly associated with respiratory failure .	On multivariate analysis , entity* monocyte count *entity , hypoxaemia , entity* confusion *entity , whole lung involvement , and entity* early cidofovir treatment *entity within 7 days from symptom onset were included , and monocyte count ( HR 0.995 , 95%CI 0.991–1.000 , p 0.042 ) , confusion ( HR 4.964 , 95%CI 1.189–20.721 , p = 0.028 ) , and early cidofovir treatment ( HR 0.319 , 95%CI 0.115–0.883 , p = 0.028 ) were significantly associated with entity* respiratory failure *entity .
Conclusions Early administration of cidofovir was associated with a lower hazard for respiratory failure development .	Conclusions entity* Early administration of cidofovir *entity was associated with a entity* lower hazard for respiratory failure development *entity .
It is suggested that cidofovir be administered within 7 days from symptom onset to prevent respiratory failure in patients with potentially severe HAdV pneumonia .	It is suggested that entity* cidofovir be administered within 7 days from symptom onset *entity to entity* prevent respiratory failure *entity in patients with potentially severe HAdV pneumonia .
Most pediatric neck masses encountered in primary care are benign , reactive lymph nodes that originate from common pediatric viral processes .	Most pediatric neck masses encountered in primary care are benign , entity* reactive lymph nodes *entity that originate from entity* common pediatric viral processes *entity .
Lesions that are larger or that have concerning features will ultimately need imaging and excisional biopsy for histopathologic confirmation of the diagnosis .	entity* Lesions *entity that are larger or that have concerning features will ultimately need entity* imaging *entity and entity* excisional biopsy *entity for entity* histopathologic confirmation of the diagnosis *entity .
A sound clinician understanding of anatomic neck spaces and common etiologies of pediatric neck masses can greatly reduce nonessential testing , cost , delay in treatment , and parental angst .	A sound entity* clinician understanding of anatomic neck spaces and common etiologies of pediatric neck masses *entity can greatly entity* reduce nonessential testing *entity , entity* cost *entity , entity* delay in treatment *entity , and entity* parental angst *entity .
Abstract Human parainfluenza viruses ( HPIVs ) are distributed worldwide and are involved mainly in the pathogenesis of respiratory tract infections .	Abstract entity* Human parainfluenza viruses ( HPIVs ) *entity are distributed worldwide and are involved mainly in the entity* pathogenesis of respiratory tract infections *entity .
The development and optimization of three quantitative reverse transcription real time polymerase chain reactions ( RT Real Time Qt - PCRs ) and an indirect immunofluorescence ( IFA ) for the detection and quantitation of HPIV-1 , -2 and -3 in clinical samples are described .	The development and optimization of three entity* quantitative reverse transcription real time polymerase chain reactions ( RT Real Time Qt - PCRs ) *entity and an entity* indirect immunofluorescence ( IFA ) *entity for the entity* detection and quantitation of HPIV-1 , -2 and -3 *entity in clinical samples are described .
Based on the results obtained , the molecular methods represent a valid and rapid tool for clinical management and should be included in diagnostic panels aimed to evaluate suspected respiratory tract infections .	Based on the results obtained , the entity* molecular methods *entity represent a valid and rapid tool for entity* clinical management *entity and should be included in entity* diagnostic panels *entity aimed to evaluate entity* suspected respiratory tract infections *entity .
Samples were analyzed by using an automated dry - slide chemistry analyzer at time 0 and then stored as aliquots for analysis at time points including day 7 , 30 , 90 , and 360 .	entity* Samples were analyzed *entity by using an entity* automated dry - slide chemistry analyzer *entity at time 0 and then entity* stored as aliquots *entity for analysis at time points including day 7 , 30 , 90 , and 360 .
Factors such as storage time and temperature should be considered when designing any retrospective study .	Factors such as entity* storage time *entity and entity* temperature *entity should be considered when entity* designing any retrospective study *entity .
Interactions can be static , such as spatial overlap , or dynamic based on the interactions of movements , and can be mediated through communication , such as the deployment of scent marks .	entity* Interactions *entity can be static , such as spatial overlap , or dynamic based on the interactions of movements , and can be mediated through entity* communication *entity , such as the entity* deployment of scent marks *entity .
With the use of GPS collars we quantify both static and dynamic interactions between male cheetahs ( Acinonyx jubatus ) and the behavioural outcomes .	With the use of entity* GPS collars *entity we entity* quantify both static and dynamic interactions between male cheetahs ( Acinonyx jubatus ) *entity and the entity* behavioural outcomes *entity .
Despite this overlap , male cheetahs rarely came into close proximity of one another , possibly because presence was communicated through frequent visits to marking posts .	Despite this overlap , male entity* cheetahs *entity rarely came into close proximity of one another , possibly because entity* presence was communicated *entity through entity* frequent visits to marking posts *entity .
After a possible encounter male cheetahs stayed in close proximity to each other for up to 6 hours , which could be the result of a territory defence strategy or the presence of a receptive female .	After a possible encounter entity* male cheetahs stayed in close proximity *entity to each other for up to 6 hours , which could be the result of a entity* territory defence strategy *entity or the entity* presence of a receptive female *entity .
We believe that one of the encounters between a singleton and a 5-male coalition resulted in the death of the singleton .	We believe that one of the entity* encounters between a singleton and a 5-male coalition *entity resulted in the entity* death of the singleton *entity .
We describe a new approach for infectious disease surveillance that facilitates rapid identification of known and emerging pathogens .	We describe a new approach for entity* infectious disease surveillance *entity that facilitates entity* rapid identification of known and emerging pathogens *entity .
The process uses broad - range polymerase chain reaction ( PCR ) to amplify nucleic acid targets from large groupings of organisms , electrospray ionization mass spectrometry for accurate mass measurements of PCR products , and base composition signature analysis to identify organisms in a sample .	entity* The process *entity uses entity* broad - range polymerase chain reaction ( PCR ) *entity to entity* amplify nucleic acid targets from large groupings of organisms *entity , entity* electrospray ionization mass spectrometry *entity for entity* accurate mass measurements of PCR products *entity , and entity* base composition signature analysis *entity to entity* identify organisms in a sample *entity .
Although single stranded ( ss ) DNA viruses that infect humans and their domesticated animals do not generally cause major diseases , the arthropod borne ssDNA viruses of plants do , and as a result seriously constrain food production in most temperate regions of the world .	Although entity* single stranded ( ss ) DNA viruses *entity that entity* infect humans *entity and their entity* domesticated animals *entity do not generally cause entity* major diseases *entity , the arthropod borne entity* ssDNA viruses of plants *entity do , and as a result seriously entity* constrain food production *entity in most temperate regions of the world .
The host ranges of these viruses probably span the tree of life and they are likely to be important components of global ecosystems .	The host ranges of entity* these viruses *entity probably span the tree of life and they are likely to be important components of entity* global ecosystems *entity .
Various lines of evidence suggest that a pivotal evolutionary process during the generation of this global ssDNA virus diversity has probably been genetic recombination .	Various lines of evidence suggest that a pivotal evolutionary process during the generation of this entity* global ssDNA virus diversity *entity has probably been entity* genetic recombination *entity .
High rates of homologous recombination , non - homologous recombination and genome component reassortment are known to occur within and between various different ssDNA virus species and we look here at the various roles that these different types of recombination may play , both in the day - to - day biology , and in the longer term evolution , of these viruses .	High rates of entity* homologous recombination *entity , entity* non - homologous recombination *entity and entity* genome component reassortment *entity are known to occur within and between various entity* different ssDNA virus species *entity and we look here at the various roles that these different types of recombination may play , both in the entity* day - to - day biology , and in the longer term evolution , of these viruses *entity .
We specifically focus on the ecological , biochemical and selective factors underlying patterns of genetic exchange detectable amongst the ssDNA viruses and discuss how these should all be considered when assessing the adaptive value of recombination during ssDNA virus evolution .	We specifically focus on the entity* ecological , biochemical and selective factors *entity underlying patterns of entity* genetic exchange detectable amongst the ssDNA viruses *entity and discuss how these should all be considered when assessing the entity* adaptive value of recombination *entity during ssDNA virus evolution .
Abstract Influenza viruses exhibit a fascinating level of antigenic heterogeneity that facilitates re - infection in the human population .	Abstract entity* Influenza viruses *entity exhibit a fascinating level of entity* antigenic heterogeneity *entity that facilitates entity* re - infection in the human population *entity .
The human antibody repertoire also manifests endless capability for variation in the genes that specify the portion of antibody molecules interacting with epitopes .	The entity* human antibody repertoire *entity also manifests endless capability for entity* variation in the genes that specify the portion of antibody molecules interacting with epitopes *entity .
A recent explosion of techniques for isolating human monoclonal antibodies to viruses has led to isolation of new antibodies that allow glimpses into the molecular basis for recognition and escape that underlies the constant antigenic drift in influenza surface proteins .	A recent explosion of techniques for entity* isolating human monoclonal antibodies to viruses *entity has led to entity* isolation of new antibodies *entity that allow glimpses into the entity* molecular basis for recognition and escape *entity that underlies the constant entity* antigenic drift in influenza surface proteins *entity .
Respiratory syncytial virus ( RSV ) is a widely distributed pathogen that causes severe disease in children , the elderly , and immunocompromised individuals .	entity* Respiratory syncytial virus ( RSV ) *entity is a widely distributed pathogen that causes entity* severe disease in children , the elderly , and immunocompromised individuals *entity .
Both vaccine development and drug discovery have been hampered by the inherent instability of the virus itself .	Both entity* vaccine development *entity and entity* drug discovery *entity have been hampered by the entity* inherent instability of the virus *entity itself .
Using frozen RSV - infected cells as the source of infectious material , we have overcome the problem of virus instability and validated a cell - based high - throughput screening assay to screen for inhibitors of RSV - induced cytopathic effect .	Using entity* frozen RSV - infected cells *entity as the entity* source of infectious material *entity , we have overcome the problem of entity* virus instability *entity and validated a entity* cell - based high - throughput screening assay *entity to entity* screen for inhibitors of RSV - induced cytopathic effect *entity .
The assay was validated with 1,280 compounds identified as potentially active against RSV ( Long strain ) in a virus - based screen .	The assay was validated with 1,280 entity* compounds identified as potentially active against RSV ( Long strain ) *entity in a entity* virus - based screen *entity .
Pathogens causing significant respiratory disease in growing pigs include Porcine reproductive and respiratory syndrome virus , Porcine circovirus 2 , swine influenza virus , porcine respiratory coronavirus , Mycoplasma hyopneumoniae , and Bordetella bronchiseptica .	entity* Pathogens *entity causing significant entity* respiratory disease in growing pigs *entity include entity* Porcine reproductive and *entity respiratory syndrome virus , Porcine circovirus 2 , entity* swine influenza virus *entity , entity* porcine respiratory coronavirus *entity , entity* Mycoplasma hyopneumoniae *entity , and entity* Bordetella bronchiseptica *entity .
The objective of this research was to characterize the respiratory excretion of these pathogens by acutely infected pigs .	The objective of this research was to characterize the entity* respiratory excretion of these pathogens *entity by entity* acutely infected pigs *entity .
C - reactive protein ( CRP ) and myxovirus resistance protein A ( MxA ) are associated with bacterial and viral infections , respectively .	entity* C - reactive protein ( CRP ) *entity and entity* myxovirus resistance protein A ( MxA ) *entity are associated with entity* bacterial and viral infections *entity , respectively .
We conducted a prospective , multicenter , cross - sectional study of adults and children with febrile upper respiratory tract infections ( URIs ) to evaluate the diagnostic accuracy of a rapid CRP / MxA immunoassay to identify clinically significant bacterial infection with host response and acute pathogenic viral infection .	We conducted a entity* prospective , multicenter , cross - sectional study *entity of entity* adults and children with febrile upper respiratory tract infections ( URIs ) *entity to entity* evaluate the diagnostic accuracy *entity of a entity* rapid CRP / MxA immunoassay *entity to identify entity* clinically significant bacterial infection with host response *entity and entity* acute pathogenic viral infection *entity .
The reference standard for classifying URI etiology was an algorithm that included throat bacterial culture , upper respiratory PCR for viral and atypical pathogens , procalcitonin , white blood cell count , and bandemia .	The reference standard for entity* classifying URI etiology *entity was an entity* algorithm *entity that included entity* throat bacterial culture *entity , entity* upper respiratory PCR *entity for entity* viral and atypical pathogens *entity , entity* procalcitonin *entity , entity* white blood cell count *entity , and entity* bandemia *entity .
The algorithm also allowed for physician override .	The entity* algorithm *entity also allowed for entity* physician override *entity .
ABSTRACT Treatment of severe acute respiratory syndrome ( SARS ) is experimental , and the effectiveness of ribavirin - steroid therapy is unclear .	ABSTRACT entity* Treatment *entity of entity* severe acute respiratory syndrome ( SARS ) *entity is experimental , and the effectiveness of entity* ribavirin - steroid therapy *entity is unclear .
Forty SARS patients with progressive disease after ribavirin treatment and 1.5 g of pulsed methylprednisolone were given either convalescent plasma ( n = 19 ) or further pulsed methylprednisolone ( n = 21 ) in a retrospective non - randomised study .	Forty entity* SARS patients with progressive disease *entity after entity* ribavirin treatment *entity and 1.5 g of entity* pulsed methylprednisolone *entity were given either entity* convalescent plasma *entity ( n = 19 ) or further pulsed methylprednisolone ( n = 21 ) in a entity* retrospective non - randomised study *entity .
Coronavirus 3C - like protease ( 3CLpro ) , which is involved in the processing of viral polyproteins for viral replication , is an appealing antiviral drug target .	entity* Coronavirus 3C - like protease ( 3CLpro ) *entity , which is involved in the entity* processing of viral polyproteins *entity for viral replication , is an appealing entity* antiviral drug target *entity .
Furthermore , the non - conserved motifs in the pockets cause different cleavage of substrate between PEDV and SARS - CoV 3CLpros , which may provide new insights into the recognition of substrates by 3CLpros in various coronavirus genera .	Furthermore , the entity* non - conserved motifs in the pockets *entity cause different entity* cleavage of substrate between PEDV and SARS - CoV 3CLpros *entity , which may provide new insights into the entity* recognition of substrates *entity by 3CLpros in various entity* coronavirus genera *entity .
Abstract Receptors for the Fc portion of immunoglobulins ( FcRs ) account for most cell - mediated biological activities of antibodies .	Abstract entity* Receptors *entity for the entity* Fc portion of immunoglobulins ( FcRs ) *entity account for most entity* cell - mediated biological activities of antibodies *entity .
They altogether form a single family within the immunoreceptor family , whose members fulfill distinct but complementary roles in immunity by differentially controlling innate and adaptive responses .	They altogether form a single family within the entity* immunoreceptor family , whose members *entity fulfill distinct but complementary roles in entity* immunity *entity by entity* differentially controlling innate and adaptive responses *entity .
Outbreaks of gastroenteritis may lead to serious disruption when many persons are absent from work or school .	Outbreaks of entity* gastroenteritis *entity may lead to serious entity* disruption when many persons are absent from work or school *entity .
Control of gastroenteritis associated with microbial infection is therefore an important aspect of preventive medicine .	Control of entity* gastroenteritis *entity associated with entity* microbial infection *entity is therefore an important aspect of preventive medicine .
The examination of faecal samples in the microbiology laboratory is becoming increasingly complex requiring as it does the use of additional new techniques for previously unrecognised bacterial , viral and protozoal causes of gastroenteritis including , in the last two decades , Campylobacter , Clostridium difficile , rotavirus , Norwalk virus and Cryptosporidium .	The entity* examination of faecal samples in the microbiology laboratory *entity is becoming increasingly complex requiring as it does the use of additional entity* new techniques *entity for previously unrecognised entity* bacterial *entity , entity* viral *entity and entity* protozoal *entity causes of entity* gastroenteritis *entity including , in the last two decades , entity* Campylobacter *entity , entity* Clostridium difficile *entity , entity* rotavirus *entity , entity* Norwalk virus *entity and entity* Cryptosporidium *entity .
We then derive from the classic SIR model a two - way fixed - effects model and apply it to the data with controls for unmeasured differences between counties and over time .	We then entity* derive from the classic SIR model *entity a entity* two - way fixed - effects model *entity and apply it to the entity* data *entity with entity* controls for unmeasured differences between counties and over time *entity .
A hypothetical national stay - at - home order issued on March 13 , 2020 when a national emergency was declared might have reduced cumulative infections by 63.3 % , and might have helped to reverse exponential growth in the disease by April 10 .	A hypothetical entity* national stay - at - home order *entity issued on March 13 , 2020 when a national emergency was declared might have entity* reduced cumulative infections *entity by 63.3 % , and might have helped to entity* reverse exponential growth in the disease *entity by April 10 .
The results here suggest that a coordinated nationwide stay - at - home order may have reduced by hundreds of thousands the current number of infections and by tens of thousands the total number of deaths from COVID-19 .	The results here suggest that a entity* coordinated nationwide stay - at - home order *entity may have reduced by hundreds of thousands the current entity* number of infections and by *entity tens of thousands the total number of deaths from COVID-19 .
Future efforts in the United States and elsewhere to control pandemics should coordinate stay - at - home orders at the national level , especially for diseases for which local spread has already occurred and testing availability is delayed .	Future entity* efforts in the United States and elsewhere *entity to entity* control pandemics *entity should entity* coordinate stay - at - home orders at the national level *entity , especially for entity* diseases for which local spread has already occurred and testing availability is delayed *entity .
In general , a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection .	In general , a whole entity* virion *entity serves as a entity* simple vaccine antigen *entity and often essential material for the entity* analysis of immune responses *entity against virus infection .
In order to develop an effective vaccine and diagnostic tools , we prepared UV - inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 ( BSL3 ) regulation .	In order to develop an entity* effective vaccine *entity and entity* diagnostic tools *entity , we prepared entity* UV - inactivated SARS coronavirus *entity on a large scale under the strict entity* Biosafety Level 3 ( BSL3 ) regulation *entity .
Our protocol for large - scale preparation of UV - inactivated SARS - CoV including virus expansion , titration , inactivation , and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future .	Our entity* protocol for large - scale preparation of UV - inactivated SARS - CoV *entity including entity* virus expansion *entity , entity* titration *entity , entity* inactivation *entity , and entity* ultracentrifugation *entity is applicable to entity* any newly emerging virus *entity we might encounter in the future .
Abstract The use of molecular epidemiology is an important tool in understanding and consequently controlling FMDV .	Abstract The use of entity* molecular epidemiology *entity is an important tool in entity* understanding and consequently controlling FMDV *entity .
Viruses of wild and domestic animals can infect humans in a process called zoonosis , and these events can give rise to explosive epidemics such as those caused by the HIV and Ebola viruses .	entity* Viruses of wild and domestic animals *entity can entity* infect humans *entity in a process called entity* zoonosis *entity , and these events can give rise to explosive entity* epidemics *entity such as those caused by the entity* HIV *entity and entity* Ebola *entity viruses .
While humans are constantly exposed to animal viruses , those that can successfully infect and transmit between humans are exceedingly rare .	While humans are constantly exposed to entity* animal viruses *entity , those that can successfully entity* infect and transmit between humans *entity are exceedingly rare .
The key event in zoonosis is when an animal virus begins to replicate ( one virion making many ) in the first human subject .	The key event in entity* zoonosis *entity is when an entity* animal virus begins to replicate *entity ( entity* one virion making many *entity ) in the first human subject .
Only at this point will the animal virus first experience the selective environment of the human body , rendering possible viral adaptation and refinement for humans .	Only at this point will the entity* animal virus first experience the selective environment of the human body *entity , rendering possible entity* viral adaptation and refinement for humans *entity .
In addition , appreciable viral titers in this first human may enable infection of a second , thus initiating selection for viral variants with increased capacity for spread .	In addition , appreciable entity* viral titers *entity in this first human may entity* enable infection *entity of a second , thus initiating entity* selection for viral variants *entity with increased entity* capacity for spread *entity .
We assert that host genetics plays a critical role in defining which animal viruses in nature will achieve this key event of replication in a first human host .	We assert that entity* host genetics *entity plays a critical role in defining which entity* animal viruses in nature *entity will achieve this key event of entity* replication in a first human host *entity .
This is because animal viruses that pose the greatest risk to humans will have few ( or no ) genetic barriers to replicating themselves in human cells , thus requiring minimal mutations to make this jump .	This is because entity* animal viruses *entity that pose the greatest entity* risk to humans *entity will have few ( or no ) genetic barriers to entity* replicating themselves in human cells *entity , thus requiring entity* minimal mutations *entity to make this jump .
Only experimental virology provides a path to identifying animal viruses with the potential to replicate themselves in humans because this information will not be evident from viral sequencing data alone .	Only entity* experimental virology *entity provides a path to entity* identifying animal viruses with the potential to replicate themselves in humans *entity because this information will not be evident from viral sequencing data alone .
Summary Upper respiratory tract infections ( URIs ) are a major cause of morbidity among vocal arts professionals , both from their acute impairment of the vocal mechanism and their predisposing influence for the development of serious vocal sequelae .	Summary entity* Upper respiratory tract infections ( URIs ) *entity are a major cause of entity* morbidity among vocal arts professionals *entity , both from their entity* acute impairment of the vocal mechanism *entity and their entity* predisposing influence for the development of serious vocal sequelae *entity .
In this review , we present some of the salient features of currently available treatments effective against influenza , the virus family responsible for the most serious form of URI .	In this review , we present some of the salient features of currently available entity* treatments *entity effective against entity* influenza *entity , the virus family responsible for the most serious form of entity* URI *entity .
At present , these include an inactivated vaccine and four antiviral drugs , each approved in the United States and many other countries for the prevention and treatment of influenza .	At present , these include an entity* inactivated vaccine *entity and entity* four antiviral drugs *entity , each approved in the United States and many other countries for the entity* prevention and treatment of influenza *entity .
Abstract Several polypeptide products of MHV - A59 ORF 1a were characterized in MHV - A59 infected DBT cells , using antisera directed against fusionn roteins encoded in the first 6.5 kb of ORF1a .	Abstract Several entity* polypeptide products *entity of entity* MHV - A59 ORF 1a *entity were entity* characterized in MHV - A59 infected DBT cells *entity , using entity* antisera directed against fusionn roteins *entity encoded in the first 6.5 kb of ORF1a .
These data suggest that different protease activities may be responsible for the cleavage of p28 in vitro and in vivo .	These data suggest that different entity* protease activities *entity may be responsible for the entity* cleavage of p28 in vitro and in vivo *entity .
The 290-kDa protein was an intermediate cleavage product derived from a precursor of greater than 400 kDa .	The entity* 290-kDa protein *entity was an entity* intermediate cleavage product *entity derived from a precursor of greater than 400 kDa .
The intracellular cleavage of the 290-kDa polypeptide was inhibited by leupeptin at concentrations which did not inhibit the early cleavage of p28 or the cleavage of the 290-kDa product from its larger polyprotein precursor .	The entity* intracellular cleavage of the 290-kDa polypeptide *entity was inhibited by entity* leupeptin *entity at concentrations which did not inhibit the early cleavage of p28 or the cleavage of the 290-kDa product from its larger polyprotein precursor .
This suggests that at least two protease activities may be necessary for processing of ORF1a proteins , one of which cleaves p28 and is sensitive to zinc chloride but resistant to leupeptin , and the other which cleaves the 290-kDa precursor and is sensitive to both inhibitors .	This suggests that at least two entity* protease activities *entity may be necessary for entity* processing of ORF1a proteins *entity , one of which entity* cleaves p28 and is *entity sensitive to entity* zinc chloride *entity but resistant to entity* leupeptin *entity , and the other which cleaves the 290-kDa precursor and is sensitive to entity* both inhibitors *entity .
Critical decisions were triggered by extraneous factors and administrative actions were shaped by dramatic switches from one set of standard operating procedures to another , as events unfolded .	entity* Critical decisions *entity were triggered by entity* extraneous factors *entity and entity* administrative actions *entity were shaped by entity* dramatic switches from one set of standard operating procedures to another *entity , as events unfolded .
Middle East respiratory syndrome coronavirus ( MERS‐CoV ) is caused by a novel betacoronavirus that was isolated in late 2012 in Saudi Arabia .	entity* Middle East respiratory syndrome coronavirus ( MERS‐CoV ) *entity is caused by a entity* novel betacoronavirus *entity that was isolated in late 2012 in Saudi Arabia .
The viral infections have been reported in more than 1700 humans , ranging from asymptomatic or mild cases to severe pneumonia with a mortality rate of 40 % .	The entity* viral infections *entity have been reported in more than 1700 humans , ranging from entity* asymptomatic or mild cases *entity to entity* severe pneumonia *entity with a entity* mortality rate of 40 % *entity .
There is no approved antiviral drug or vaccine against MERS‐CoV despite the active research in this area .	There is no approved entity* antiviral drug *entity or entity* vaccine *entity against entity* MERS‐CoV *entity despite the active research in this area .
The mechanism of camel to human transmission is still not clear , but several primary cases have been associated with camel contact .	The mechanism of entity* camel to human transmission *entity is still not clear , but several primary cases have been associated with camel contact .
Vaccine candidates have been developed using various platforms and regimens and have been tested in several animal models .	entity* Vaccine candidates *entity have been developed using various entity* platforms and regimens *entity and have been tested in several entity* animal models *entity .
Here , this article reviews the published studies on MERS‐CoV vaccines with more focus on vaccines tested in large animals , including camels .	Here , this article reviews the published studies on entity* MERS‐CoV vaccines *entity with more focus on vaccines tested in entity* large animals *entity , including entity* camels *entity .
It is foreseeable that the 1‐health approach could be the best way of tackling the MERS‐CoV endemic in the Arabian Peninsula , by using the mass vaccination of camels in the affected areas to block camel to human transmission .	It is foreseeable that the entity* 1‐health approach *entity could be the best way of entity* tackling the MERS‐CoV endemic *entity in the Arabian Peninsula , by using the entity* mass vaccination of camels *entity in the affected areas to entity* block camel to human transmission *entity .
It is well documented now that dromedary camels contract the infection and shed the virus without notable symptoms , and such animals had been infected by at least the early 1980s .	It is well documented now that entity* dromedary camels *entity entity* contract the infection and shed the virus without notable symptoms *entity , and such animals had been infected by at least the early 1980s .
This chapter discusses important and interesting lessons our HCI team have learned from our involvement with the design , development , and evaluation of CBRNE - related projects over the last decade .	This chapter discusses important and interesting lessons our HCI team have learned from our involvement with the entity* design *entity , entity* development *entity , and entity* evaluation *entity of entity* CBRNE *entity - related projects over the last decade .
Summary Background Avian influenza A H6N1 virus is one of the most common viruses isolated from wild and domestic avian species , but human infection with this virus has not been previously reported .	Summary Background entity* Avian influenza A H6N1 virus *entity is one of the most common viruses isolated from wild and domestic entity* avian species *entity , but human infection with this virus has not been previously reported .
We report the clinical presentation , contact , and environmental investigations of a patient infected with this virus , and assess the origin and genetic characteristics of the isolated virus .	We report the entity* clinical presentation *entity , entity* contact *entity , and entity* environmental investigations *entity of a entity* patient infected with this virus *entity , and entity* assess *entity the entity* origin *entity and entity* genetic characteristics *entity of the isolated virus .
Methods A 20-year - old woman with an influenza - like illness presented to a hospital with shortness of breath in May , 2013 .	Methods A 20-year - old woman with an entity* influenza - like illness *entity presented to a hospital with entity* shortness of breath *entity in May , 2013 .
An unsubtyped influenza A virus was isolated from her throat - swab specimen and was transferred to the Taiwan Centres for Disease Control ( CDC ) for identification .	An entity* unsubtyped influenza A virus was isolated *entity from her entity* throat - swab *entity specimen and was entity* transferred to the Taiwan Centres for Disease Control *entity ( CDC ) for entity* identification *entity .
The medical records were reviewed to assess the clinical presentation .	entity* The medical records were reviewed *entity to entity* assess the clinical presentation *entity .
We did a contact and environmental investigation and collected clinical specimens from the case and symptomatic contacts to test for influenza virus .	We did a entity* contact and environmental investigation *entity and entity* collected clinical specimens *entity from the entity* case and symptomatic contacts *entity to entity* test for influenza virus *entity .
Sequence analyses showed that this human isolate was highly homologous to chicken H6N1 viruses in Taiwan and had been generated through interclade reassortment .	entity* Sequence analyses *entity entity* showed that this human isolate was highly homologous to chicken H6N1 viruses *entity in Taiwan and had been entity* generated *entity through entity* interclade reassortment *entity .
Notably , the virus had a G228S substitution in the haemagglutinin protein that might increase its affinity for the human α2 - 6 linked sialic acid receptor .	Notably , the virus had a entity* G228S substitution *entity in the haemagglutinin protein that might entity* increase its affinity for the human α2 - 6 linked sialic acid receptor *entity .
A unique clade of H6N1 viruses with a G228S substitution of haemagglutinin have circulated persistently in poultry in Taiwan .	A unique clade of H6N1 viruses with a entity* G228S substitution *entity of haemagglutinin have entity* circulated persistently in poultry *entity in Taiwan .
These viruses continue to evolve and accumulate changes , increasing the potential risk of human - to - human transmission .	entity* These viruses *entity continue to entity* evolve *entity and entity* accumulate changes *entity , entity* increasing the potential risk of human - to - human transmission *entity .
Our report highlights the continuous need for preparedness for a pandemic of unpredictable and complex avian influenza .	entity* Our report *entity highlights the continuous need for preparedness for a entity* pandemic of unpredictable and complex avian influenza *entity .
Viral infections frequently induce acute and chronic inflammatory diseases , yet the contribution of the innate immune response to a detrimental host response remains poorly understood .	entity* Viral infections *entity frequently entity* induce acute and chronic inflammatory diseases *entity , yet the contribution of the entity* innate immune response *entity to a entity* detrimental host response *entity remains poorly understood .
In virus - infected cells , double - stranded RNA ( dsRNA ) is generated as an intermediate during viral replication .	In entity* virus - infected cells *entity , entity* double - stranded RNA ( dsRNA ) is generated *entity as entity* an intermediate during viral replication *entity .
Cell necrosis ( and the release of endogenous dsRNA ) is a common event during both sterile and infectious inflammatory processes .	entity* Cell necrosis *entity ( and the entity* release of endogenous dsRNA *entity ) is a common event during both entity* sterile and infectious inflammatory processes *entity .
Varying susceptibility to infection and disease outcomes have been reported in TLR3-immunodeficient mice .	entity* Varying susceptibility to infection and disease outcomes *entity have been reported in entity* TLR3-immunodeficient mice *entity .
Data are conflicting on the role of TLR3 in protective immunity against viruses in the mouse model .	Data are conflicting on the role of entity* TLR3 *entity in protective entity* immunity against viruses *entity in the mouse model .
Surprisingly , the susceptibility to develop herpes simplex virus-1 encephalitis in humans with inborn defects of the TLR3 pathway varies , and TLR3-deficient humans do not show increased susceptibility to other viral infections .	Surprisingly , the entity* susceptibility to develop herpes simplex virus-1 encephalitis *entity in humans with entity* inborn defects of the TLR3 pathway *entity varies , and TLR3-deficient humans do not show increased susceptibility to other viral infections .
Therefore , a current challenge is to understand the protective versus pathogenic contribution of TLR3 in viral infections .	Therefore , a current challenge is to understand the protective versus pathogenic contribution of entity* TLR3 *entity in entity* viral infections *entity .
We review recent advances in the identification of TLR3-signalling pathways , endogenous and virus - induced negative regulators of the TLR3 cascade , and discuss the protective versus pathogenic role of TLR3 in viral pathogenesis .	We review recent advances in the identification of TLR3-signalling pathways , entity* endogenous and virus - induced negative regulators *entity of the entity* TLR3 cascade *entity , and discuss the protective versus pathogenic role of TLR3 in entity* viral pathogenesis *entity .
The cotranslational folding is recognized as a very cooperative process that occurs after the nearly completion of the polypeptide sequence of a domain .	The entity* cotranslational folding *entity is recognized as a very cooperative process that entity* occurs after the nearly completion of the polypeptide sequence of a domain *entity .
Some highly pathogenic viruses , such as Chikungunya virus , Japanese encephalitis virus , Yellow fever virus , Dengue virus , Hanta virus , SARS‐CoV , and H5N1 avian influenza virus can cause severe infectious diseases .	Some entity* highly pathogenic viruses *entity , such as entity* Chikungunya virus *entity , entity* Japanese encephalitis virus *entity , entity* Yellow fever virus *entity , entity* Dengue virus *entity , entity* Hanta virus *entity , entity* SARS‐CoV *entity , and entity* H5N1 avian influenza virus *entity can cause entity* severe infectious diseases *entity .
A rapid and sensitive microarray approach for detection of these viruses and a panel of specific probes covering nine genera and 16 virus species were designed .	entity* A rapid and sensitive microarray approach *entity for entity* detection of these viruses *entity and a panel of specific probes covering nine genera and 16 virus species were designed .
This microarray‐based method used the highly conserved consensus primers to synthesize specifically the virus cDNA and could identify effectively Chikungunya virus , Japanese encephalitis virus , Yellow fever virus , Dengue virus , Tick borne encephalitis virus , and H5N1 avian influenza virus .	entity* This microarray‐based method *entity used entity* the highly conserved consensus primers to synthesize specifically the virus cDNA *entity and could entity* identify effectively Chikungunya virus , Japanese encephalitis virus , Yellow fever virus , Dengue virus , Tick borne encephalitis virus , and H5N1 avian influenza virus *entity .
Background Standard precautions ( SPs ) serve as the first line of defense against exposure to blood and body fluids .	Background entity* Standard precautions ( SPs ) *entity serve as the first line of entity* defense against exposure to blood and body fluids *entity .
Results A higher , or positive , attitude was the strongest influencing factor in adherence to SPs in the final model , followed by administrative support , hospital types , and safety climate , in descending order .	Results entity* A higher , or positive , attitude *entity was the strongest influencing factor in entity* adherence to SPs *entity in the final model , followed by entity* administrative support *entity , entity* hospital types *entity , and entity* safety climate *entity , in descending order .
Conclusions The attitudes of nurses toward SPs is important for increasing the adherence to SP best practices .	Conclusions The entity* attitudes of nurses toward SPs *entity is important for increasing the entity* adherence to SP best practices *entity .
The adherence of nurses to SPs will improve if safe environments are created in different hospital types and if managerial support and administrative efforts are supportive and sustained .	The entity* adherence of nurses to SPs *entity will improve if entity* safe environments are created in different hospital types *entity and if entity* managerial support *entity and entity* administrative efforts *entity are supportive and sustained .
Abstract The multi - domain non - structural protein 3 of SARS - coronavirus is a component of the viral replication / transcription complex ( RTC ) .	Abstract The entity* multi - domain non - structural protein 3 of SARS - coronavirus *entity is a component of the entity* viral replication / transcription complex ( RTC ) *entity .
Induction of immune coagulants has been implicated in the pathogenesis of murine hepatitis virus strain 3 ( MHV-3)-induced fulminant hepatic necrosis .	entity* Induction of immune coagulants *entity has been implicated in the entity* pathogenesis of murine hepatitis virus strain 3 ( MHV-3)-induced fulminant hepatic necrosis *entity .
Previous work from our laboratory has shown that the induction of procoagulant activity ( PCA ) correlates with the resistance / susceptibility to disease in inbred and recombinant inbred ( RI ) strains of mice .	Previous work from our laboratory has shown that the entity* induction of procoagulant activity ( PCA ) *entity correlates with the entity* resistance / susceptibility to disease in inbred and recombinant inbred ( RI ) strains of mice *entity .
Macrophages from susceptible , but not resistant , strains of mice expressed increased levels of PCA in response to MHV-3 stimulation .	Macrophages from susceptible , but not resistant , strains of mice expressed entity* increased levels of PCA *entity in response to entity* MHV-3 stimulation *entity .
T lymphocytes , however , had a marked regulatory role in the final expression of macrophage PCA .	entity* T lymphocytes *entity , however , had a marked entity* regulatory role in the final expression of macrophage PCA *entity .
In this present study , T - cell lines were derived from draining popliteal lymph nodes from resistant A / J mice , which had been immunized with MHV-3 .	In this present study , entity* T - cell lines were derived *entity from entity* draining popliteal lymph nodes *entity from entity* resistant A / J mice *entity , which had been entity* immunized with MHV-3 *entity .
All of the CD4 + cell lines produced IL-2 and two produced interferon - gamma ( IFN - gamma ) , consistent with the Th1 cytokine profile .	All of the entity* CD4 + cell lines *entity entity* produced IL-2 *entity and two produced entity* interferon - gamma ( IFN - gamma ) *entity , consistent with the Th1 cytokine profile .
One cell line ( 3E9.1 ) was able to inhibit the induction of macrophage PCA through production of a soluble factor although cell - to - cell contact could not be excluded .	One entity* cell line ( 3E9.1 ) *entity was able to entity* inhibit the induction of macrophage PCA *entity through entity* production of a soluble factor *entity although cell - to - cell contact could not be excluded .
This CD4 + T - cell line conferred protection to infected and susceptible AXB8 mice .	This entity* CD4 + T - cell line *entity conferred entity* protection to infected and susceptible AXB8 mice *entity .
These results demonstrate that the existence of a Th1 subpopulation of cells with a regulatory effect on macrophage PCA induction in MHV-3-infected mice contributes to the resistance of the A / J strain of mice to MHV-3 infection .	These results demonstrate that the existence of a entity* Th1 subpopulation of cells *entity with a entity* regulatory effect on macrophage PCA induction *entity in MHV-3-infected mice contributes to the entity* resistance of the A / J strain of mice to MHV-3 infection *entity .
With the emergence of SARS - CoV-2 and the associated Coronavirus disease 2019 ( COVID-19 ) , there is an imperative need for diagnostic tests that can identify the infection .	With the emergence of entity* SARS - CoV-2 *entity and the associated entity* Coronavirus disease 2019 ( COVID-19 ) *entity , there is an imperative need for entity* diagnostic tests *entity that can entity* identify the infection *entity .
Although Nucleic Acid Test ( NAT ) is considered to be the gold standard , serological tests based on antibodies could be very helpful .	Although Nucleic Acid Test ( NAT ) is considered to be the gold standard , entity* serological tests *entity based on entity* antibodies *entity could be very helpful .
We performed a systematic review and meta - analysis following the PRISMA guidelines .	We performed a entity* systematic review *entity and entity* meta - analysis *entity following the entity* PRISMA guidelines *entity .
However , individual studies measuring the accuracy of the various tests are usually underpowered and inconsistent , thus , a comparison of different tests is needed .	However , individual entity* studies *entity entity* measuring the accuracy of the various tests *entity are usually underpowered and inconsistent , thus , a comparison of different tests is needed .
We conducted the literature search in PubMed , medRxiv and bioRxiv .	We conducted the entity* literature search *entity in entity* PubMed *entity , entity* medRxiv *entity and entity* bioRxiv *entity .
For the statistical analysis we used the bivariate method for meta - analysis of diagnostic tests pooling sensitivities and specificities .	For the entity* statistical analysis *entity we used the entity* bivariate method *entity for entity* meta - analysis *entity of entity* diagnostic tests pooling sensitivities and specificities *entity .
We created an anti - tumor vaccine by using adenovirus as a vector which contains a cytomegalovirus early promoter - directed human carcinoembryonic antigen gene ( AdCMV - hCEA ) .	We created an entity* anti - tumor vaccine *entity by using entity* adenovirus as a vector *entity which contains a entity* cytomegalovirus early promoter - directed human carcinoembryonic antigen gene ( AdCMV - hCEA ) *entity .
The levels of adenylate kinase 1 , β - enolase , creatine kinase M chain , hemoglobin beta chain and prohibitin were statistically increased whereas the level of a creatine kinase fragment , which is undocumented , was decreased in the tumor of vaccinated mice .	The levels of entity* adenylate kinase 1 , β - enolase *entity , entity* creatine kinase M chain *entity , entity* hemoglobin beta chain and prohibitin *entity were statistically increased whereas the level of a creatine kinase fragment , which is undocumented , was decreased in the tumor of entity* vaccinated mice *entity .
These proteins may provide a vital link between early - stage tumor suppression and immune response of skin patch vaccination .	entity* These proteins *entity may provide a vital link between entity* early - stage tumor suppression *entity and entity* immune response *entity of entity* skin patch vaccination *entity .
The 3C‐like protease ( 3CL(pro ) ) is essential for viral replication and thus represents a potential target for antiviral drug development .	The entity* 3C‐like protease ( 3CL(pro ) ) *entity is essential for entity* viral replication *entity and thus represents a potential target for entity* antiviral drug development *entity .
HKU4‐CoV 3CL(pro ) shares high sequence identity ( 81 % ) with the MERS‐CoV enzyme and thus represents a potential surrogate model for anti‐MERS drug discovery .	entity* HKU4‐CoV 3CL(pro ) *entity shares high sequence identity ( 81 % ) with the MERS‐CoV enzyme and thus represents a entity* potential surrogate model *entity for entity* anti‐MERS drug discovery *entity .
